Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|December 6, 2005
Serum EGFR levels and efficacy of trastuzumab-based therapy in patients with metastatic breast cancerGernot Hudelist, Wolfgang J Köstler, Daphne Gschwantler-Kaulich, et al.
Endocrine-Related Cancer|October 25, 2008
Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cellsChristian F Singer, Gernot Hudelist, Eva-Maria Fuchs, et al.
International Journal of Cancer|September 15, 2005
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancerGernot Hudelist, Wolfgang J Köstler, Klaus Czerwenka, et al.
Journal of Minimally Invasive Gynecology|May 31, 2024
Non-Invasive Imaging Techniques for Diagnosis of Pelvic Deep Endometriosis and Endometriosis Classification Systems: An International Consensus StatementGeorge Condous, Bassem Gerges, Isabelle Thomassin-Naggara, et al.
Anti-Cancer Drugs|January 19, 2005
Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experienceWolfgang J Köstler, Günther G Steger, Michael Krainer, et al.
Plos One|March 3, 2017
PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancerDaphne Gschwantler-Kaulich, Yen Y Tan, Eva-Maria Fuchs, et al.
Fertility and Sterility|December 31, 2025
Ultrasound as a non-invasive diagnostic tool to detect deep endometriosis using the International Deep Endometriosis Analysis terminologyCeline Bafort, George Condous, Dominique Van Schoubroeck, et al.
Journal of Cancer Research and Clinical Oncology|May 3, 2005
The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 statusWolfgang J Köstler, Thomas Brodowicz, Gernot Hudelist, et al.
Pageof 11